Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bexagliflozin in T2DM with Moderate Renal Impairment
NCT02836873Phase 3Completed
- Sponsor
- Theracos, Inc.
- Start
- Sep 2016
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of bexagliflozin in type 2 diabetes mellitus (T2DM), sponsored by Theracos, Inc.. Started Sep 2016; status: completed.
02
Drugs
bexagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02836873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02836873.